Announcements Trials
Browse Landscape

Phase

Phase 3 6Phase 2 4

Status

Completed 5Terminated 1

Sponsor Class

INDUSTRY 4OTHER 1NETWORK 1

Study Type

Interventional 6

Sponsor

Cancer Type

Gastrointestinal 4Breast 2

Conditions

Colorectal Neoplasms 2Breast Neoplasms 2Stomach Neoplasms 1Rectal Neoplasms 1Colonic Neoplasms 1

Interventions

Cisplatin 725Carboplatin 607Paclitaxel 578Cyclophosphamide 516Radiotherapy 511Docetaxel 475Fluorouracil 453Gemcitabine 437Doxorubicin 383Capecitabine 361Dexamethasone 327Oxaliplatin 288pembrolizumab 283Leucovorin 282Bevacizumab 275Etoposide 271Vincristine 270Rituximab 246Prednisone 222Pemetrexed 217Cytarabine 205Drug Therapy 194Trastuzumab 175Irinotecan 172Methotrexate 171Lenalidomide 137Nivolumab 135Filgrastim 135Epirubicin 129Tamoxifen 127

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Phase 3 × Interventional × Uracil × Clear all
NCT00207831 2020-03-25

UFT RT Phase 3

Institut Cancerologie de l'Ouest

Phase 3 Terminated
219 enrolled
Gastrointestinal

Rectal Neoplasms

NCT00152178 2011-07-07

The Comparative Trial of UFT + TAM With CMF + TAM in Adjuvant Therapy for Breast Cancer (CUBC)

Taiho Pharmaceutical Co., Ltd.

Phase 3 Completed
680 enrolled
Breast

Breast Neoplasms

NCT00152191 2011-07-07

A Randomized Controlled Study of Postoperative Adjuvant Therapy of Uracil-tegafur (UFT) Compared With Cyclophosphamide/Methotrexate/5-fluorouracil (CMF) in Breast Cancer (NSAS-BC)

Taiho Pharmaceutical Co., Ltd.

Phase 3 Completed
1,300 enrolled
Breast

Breast Neoplasms

NCT00152230 2011-07-07

A Randomized Controlled Study of Postoperative Adjuvant Chemotherapy of Uracil- Tegafur (UFT) Compared With Surgery Alone (NSAS-CC)

Taiho Pharmaceutical Co., Ltd.

Phase 3 Completed
900 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT00152243 2011-07-07

A Randomized Controlled Study of Postoperative Adjuvant Chemotherapy of Uracil- Tegafur (UFT) Compared With Surgery Alone (NSAS-GC)

Taiho Pharmaceutical Co., Ltd.

Phase 3 Completed
500 enrolled
Gastrointestinal

Stomach Neoplasms

NCT00378716 2010-01-11

Combination Chemotherapy in Treating Patients With Resected Colon Cancer

NSABP Foundation Inc

Phase 3 Completed
1,608 enrolled
Gastrointestinal

Colonic Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡